Intravenous arginine benefits children after acute metabolic strokes

(Children's Hospital of Philadelphia) Children with mitochondrial diseases who suffered acute metabolic strokes benefited from rapid intravenous treatment with the amino acid arginine, experiencing no side effects from the treatment. The diseases were caused by a range of different genetic disorders. In half of the stroke episodes, patients showed clinical improvements in symptoms such as seizures and partial paralysis.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news